Compare Fameglow Holdings Ltd. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 33.03%
2
High Debt Company with a Debt to Equity ratio (avg) at times
3
Healthy long term growth as Net Sales has grown by an annual rate of 50.28%
4
The company has declared Positive results for the last 4 consecutive quarters
5
With ROE of 43.10%, it has a Expensive valuation with a 12.29 Price to Book Value
6
Market Beating performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
730.0%
0%
730.0%
6 Months
876.47%
0%
876.47%
1 Year
1797.14%
0%
1797.14%
2 Years
1343.48%
0%
1343.48%
3 Years
2229.82%
0%
2229.82%
4 Years
3305.13%
0%
3305.13%
5 Years
2113.33%
0%
2113.33%
Fameglow Holdings Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
50.28%
EBIT Growth (5y)
26.55%
EBIT to Interest (avg)
3.78
Debt to EBITDA (avg)
0.28
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
3.36
Tax Ratio
16.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
33.03%
ROE (avg)
36.57%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
12.29
EV to EBIT
24.31
EV to EBITDA
11.54
EV to Capital Employed
11.45
EV to Sales
3.02
PEG Ratio
2.25
Dividend Yield
NA
ROCE (Latest)
47.10%
ROE (Latest)
43.10%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Mar'23
Mar'23
Mar'22
Change(%)
Net Sales
227.60
179.60
26.73%
Operating Profit (PBDIT) excl Other Income
64.30
34.80
84.77%
Interest
3.80
4.90
-22.45%
Exceptional Items
2.00
3.30
-39.39%
Consolidate Net Profit
16.40
-8.80
286.36%
Operating Profit Margin (Excl OI)
76.80%
-46.80%
12.36%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2023 is 26.73% vs 118.76% in Mar 2022
Consolidated Net Profit
YoY Growth in year ended Mar 2023 is 286.36% vs 67.41% in Mar 2022
About Fameglow Holdings Ltd. 
Fameglow Holdings Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






